BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25903823)

  • 1. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
    Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magical thinking around end of life: An editorial on 'Implantable Cardioverter Defibrillator deactivation discussions: Reality vs. recommendations'.
    MacKenzie MA
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):8-9. PubMed ID: 26791007
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?
    Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
    Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
    Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.
    Goldstein NE; Mehta D; Siddiqui S; Teitelbaum E; Zeidman J; Singson M; Pe E; Bradley EH; Morrison RS
    J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):7-12. PubMed ID: 18095037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.
    Fluur C; Bolse K; Strömberg A; Thylén I
    Heart Lung; 2013; 42(3):202-7. PubMed ID: 23273655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
    Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
    Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial Survey.
    Hill L; McIlfatrick S; Taylor BJ; Jaarsma T; Moser D; Slater P; McAloon T; Dixon L; Donnelly P; Stromberg A; Fitzsimons D
    J Cardiovasc Nurs; 2018; 33(6):527-535. PubMed ID: 29727378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.
    Thylén I; Wenemark M; Fluur C; Strömberg A; Bolse K; Årestedt K
    Eur J Cardiovasc Nurs; 2014 Apr; 13(2):142-51. PubMed ID: 24298191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.